High-intensity Interval Training in Patients With Atrial Fibrillation

Atrial Fibrillation Clinical Trial

— HIIT-AF  

Official title:

Impact of High-intensity Interval Training in Patients With Atrial Fibrillation: Understanding of the Underlying Cardiovascular Mechanisms

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05354271
• Other study ID #: 21LJMUSPONSOR060
• Status: Recruiting
• Phase: N/A
• Start date: August 27, 2021
• Est. completion date: January 27, 2023

Study information

• Verified date: November 2021
• Source: Liverpool John Moores University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A key characteristic of the heart is its regular rhythm. When the heart is exposed to irregular electric impulses, such as with atrial fibrillation (AF), detrimental effects can occur affecting the ability of the heart to pump blood. AF affects more than 33 million individuals worldwide, and places individuals at increased risk for stroke, heart failure and death. Of note, being fit seems to protect the long-term severity of AF, and individuals with AF who improved their aerobic fitness seem to decrease their severity of atrial fibrillation. Although exercise training is known to improve aerobic fitness, there are limited data investigating the benefits of an exercise training program on the reduction of AF burden.

Once AF is present, regular exercise in these patients reduces the risk for developing cardiovascular events. Moreover, exercise training at high-intensity seems to bring greater adaptations in cardiac patients. This effect may be related to improvements in cardiovascular function and structure. No previous study has explored this possibility in patients with AF. Therefore, I will assess cardiac function and blood vessel quality before and after exercise training (at high- and moderate-intensities) in patients with AF. Better insight into how intensity of exercise training could affect the heart and the blood vessels can lead to better exercise recommendations in this population.

This project will contribute to improved clinical care for patients with AF, specifically related to the prescription of the optimal dose and type of exercise. This may result in fewer complications, improved quality of life, and lower socio-economic/healthcare costs.

Description:

Atrial fibrillation (AF) is the most common clinically significant arrhythmia, affecting more than 33 million individuals worldwide. AF leads to structural and electrical remodeling in both the atria and ventricles and is strongly related to an increased risk of stroke, heart failure and death. The CARDIO-FIT study demonstrated that AF patients with a higher baseline aerobic fitness were almost 3 times more likely to maintain arrhythmia freedom after a 4-year follow-up; also, AF patients who gained more than 2 metabolic equivalents (METs, aerobic fitness) were more than two-fold more likely to maintain sinus rhythm.

High-intensity exercise training and atrial fibrillation. Each METs gained was associated with a 9% decline in the risk of arrhythmia recurrence. From studies performed in patients with cardiovascular disease, high-intensity interval training (HIIT) seems to bring at least similar or greater improvements in aerobic fitness compared to a moderate-intensity continuous training (MICT). Moreover, in patients with AF, time in AF was reduced of -3.3±7.2% after 12 weeks of HIIT compared to an increased time in AF of 4.2±11.8% in a control group without exercise. Whilst this highlights the potency of HIIT, no previous study has directly compared the effects of HIIT vs. MICT in AF patients on AF burden.

Cardiovascular physiological mechanism(s). Patients with AF exhibit cardiac and vascular dysfunction. However, exercise training improves cardiac and vascular function in human, but the effects are unknown in AF patients. This knowledge is important to improve management of patients with AF with an optimal training prescription. Research on long-term effects and safety related to high-intensity exercise in AF patients is therefore warranted. The findings of the optimal training prescription will help us to update and improve the current guidelines.

Building on the latest scientific insights, the overall aim of this proposal is to determine the optimal intensity for reducing the AF burden. Moreover, the understanding of the underlying mechanisms could help us to determine the cardiovascular adaptations related to exercise training (HIIT or MICT).

Taken together, this study will answer these two questions:

1. What is the best exercise intensity for reducing the time in AF?

2. What are the underlying cardiovascular mechanisms associated with any training related decrease in AF burden? Objectives. Objective 1. High-intensity interval training and AF: The investigators will compare the effects of HIIT and MICT on the burden of AF to test the hypothesis that HIIT decreases the time in AF to a greater extent than MICT.

Objective 2. Cardiovascular physiological mechanisms: The investigators will assess cardiovascular function in all AF patients before and after the training intervention, to test the hypothesis that HIIT is associated with greater cardiovascular adaptation compared to MICT.

Methods. Experimental design: The investigators will perform a 3-arm randomised controlled trial to answer the first research question. The investigators will compare regular care (control group) with regular care + HIIT and regular care + MICT in a total of 60 stable outpatients with non-permanent AF in need for rhythm control (catheter ablation or cardioversion) on the pre-procedure burden of AF, and post-procedure recurrence. When participants are listed on the waiting list for the ablation procedure, they will be assigned to control or HIIT or MICT in a randomized order. The waiting list is approximately 3 months, so patients would have the exercise program for at least 3 months prior to the rhythm control procedure, and continue for 3 months post-procedure to assess AF recurrence. To answer the second research question, the investigators will perform cardiac and vascular functions measurements at baseline, 3 months, and 6 months training intervention in all patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: January 27, 2023
• Est. primary completion date: January 27, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Presence of non-permanent AF

• > 18 years old

Exclusion Criteria:

• Performing endurance training at high intensity >2 times/week or at moderate intensity >3 times/week;

• Previous cardiac surgery not related to AF;

• LVEF <45%;

• Severe coronary artery disease non-suitable for revascularization;

• Significant cardiac valve disease;

• Implanted cardiac pacemaker;

• And restriction to cardiopulmonary exercise testing or severe intolerance to exercise.

Related Conditions & MeSH terms

• Atrial Fibrillation

Intervention

Other:
• High-intensity interval training
Patients will cycle or walk/run four intervals of four-min at high intensity with the aim to reach 80-90% of peak oxygen consumption, 90-95% of peak heart rate, 15-17 Borg scale, shortness of breath). Each interval is separated by a three-min active recovery, at 50-60% of peak oxygen consumption or 70-75% of peak heart rate. Total exercise time will be 38 min including the warm-up and cool-down.
• Moderate-intensity continuous training
Patients will cycle or walk/run continuously at moderate intensity (50-60% of peak oxygen consumption, 70-75% of peak heart rate) for 37 min. Total exercise time will be 47 min for the Moderate-intensity continuous training group including warm-up and cool-down (isoenergetic compared to high-intensity interval training).

Locations

Country	Name	City	State
United Kingdom	Liverpool Centre for Cardiovascular Sciences	Liverpool	Merseyside

Sponsors (4)

Lead Sponsor	Collaborator
Liverpool John Moores University	Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital NHS Foundation Trust, University of Liverpool

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in burden of atrial fibrillation	Burden of atrial fibrillation (number of episodes) continually measured, and reported by the patient. Measured by Huawei Band 4 and 6	baseline and 3 months post rhythm control procedure
Secondary	Maximal oxygen uptake	VO2peak	baseline and 3 months post rhythm control procedure
Secondary	Peripheral endothelial function	FMD	baseline and 3 months post rhythm control procedure
Secondary	Carotid structure	IMT	baseline and 3 months post rhythm control procedure
Secondary	Central endothelial function	CAR	baseline and 3 months post rhythm control procedure
Secondary	Health related quality of life	Measured with the Medical Outcome Survey Short Form-36 (SF-36) questionnaire	baseline and 3 months post rhythm control procedure
Secondary	Health related quality of life	Measured with the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire	baseline and 3 months post rhythm control procedure
Secondary	Health related quality of life	Measured with the modified Mayo AF-Specific Symptom Inventory (mMAFSI) questionnaire	baseline and 3 months post rhythm control procedure
Secondary	Health related quality of life	Measured with the HeartQoL questionnaire	baseline and 3 months post rhythm control procedure
Secondary	Physical activity level	Steps, sedentary time, light (< 3 METs), moderate (3-<6 METs) and vigorous (=6 METS) physical activities, measured with the Huawei bands for 14 nights and days (24h)	baseline and 3 months post rhythm control procedure
Secondary	Resting atrial and ventricular function	Atrial and ventricular function including left ventricular function, volume, dimension of the cavities, wall thickness, blood and tissue velocities measured by echocardiography	baseline and 3 months post rhythm control procedure
Secondary	Myocardial strain	GLS, circumferential and radial strain measured by echocardiography	baseline and 3 months post rhythm control procedure
Secondary	Strain-area loop	Relation between changes in volume and strain measured by echocardiography	baseline and 3 months post rhythm control procedure
Secondary	Atrial and ventricular function during exercise	Atrial and ventricular function including left ventricular function, volume, dimension of the cavities, wall thickness, blood and tissue velocities measured by echocardiography during exercise	baseline and 3 months post rhythm control procedure